In the previous Couch Lesson on AI + COVID-19, it became clear that one of the key areas in which AI can be utilized is general health research and drug discovery. To follow up on that insight, we’re hosting this session to uncover how AI is currently being used to improve public health, how it’s facilitating the development of new drugs and what large-scale effects this set of technologies might have on healthcare in societies around the world.
What you will learn:
• How is AI used in drug discovery?
• Will improvements in AI technology make us live longer?
• Will improvements in AI technology increase life expectancy for all people?
Naomi Lee, Vice Chair at ITU/WHO Focus Group on Artificial Intelligence for Health and Senior Executive Editor, The Lancet
Maxine Mackintosh, The Alan Turing Institute, The Health Foundation and the University of Oxford / UK
Frank Noé, Professor for Mathematical Modeling in the Life Sciences, Freie Universität Berlin and Head of The AI4Science Group / DE
Tutorial and Data Protection